CYP2C19 Genotype-Directed P2Y12 Inhibitor Antiplatelet Therapy Normalizes Risk for Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention

Publication date: Available online 17 March 2021Source: Indian Heart JournalAuthor(s): Tomasz P. Stys, Maheedhar Gedela, Smitha N. Gowda, Valerie Bares, Lauren Fanta, Marian Petrasko, Catherine Hajek, Eric Larson, Adam T. Stys
Source: Indian Heart Journal - Category: Cardiology Source Type: research